BAKER BROS. ADVISORS LP
Q2 2020 13F-HR Holdings
Net value change ($000)
+6,434,758
(39.6%)
New positions
15
Sold out positions
11
Turnover %
1.8%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Seagen Inc. | 2,256,071 | 39.1% |
| INCY | 985,138 | 42.1% |
| ONC | 768,938 | 53.0% |
| BMRN | 294,769 | 46.0% |
| ACAD | 260,646 | 14.7% |
| Invitae Corp | 234,561 | 188.5% |
| MyoKardia, Inc. | 222,552 | 267.6% |
| ALXN | 196,680 | 25.0% |
| ASND | 119,643 | 31.3% |
| AMARIN CORP PLC | 100,730 | 73.0% |
Top Reduces (Value $000, Stocks/ETFs)
| Ra Pharmaceuticals, Inc. | -100,525 | -100.0% |
| Tricida, Inc. | -37,009 | -63.1% |
| Principia Biopharma Inc. | -21,592 | -18.6% |
| URGN | -12,005 | -100.0% |
| GW PHARMACEUTICALS PLC | -9,766 | -30.1% |
| KRYS | -7,059 | -17.2% |
| QURE | -6,540 | -38.6% |
| BIODELIVERY SCIENCES INTERNATIONAL INC | -6,209 | -100.0% |
| TARA | -4,592 | -100.0% |
| TPST | -4,400 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|